Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

被引：0
|
作者：
Rasmussen, Birgitte B. [1 ]
Ejlertsen, Bent [1 ]
Nielsen, Kirsten Vang [2 ]
Balslev, Eva [1 ]
Muller, Sven [2 ]
Moller, Susanne [1 ]
Mouridsen, Henning T. [1 ]
机构：
[1] DBCG, Copenhagen, Denmark
[2] Dako AS, Glostrup, Denmark
来源：
APMIS | 2008年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [41] Focal ESR1 gene amplification is an independent prognostic marker in postmenopausal patients with endocrine-responsive early breast cancer
    Singer, Christian F.
    Holst, Frederik
    Steurer, Stefan
    Burandt, Eike
    Lax, Sigurd
    Jakesz, Raimund
    Rudas, Margaretha
    Stoger, Herbert
    Greil, Richard
    Sauter, Guido
    Filipits, Martin
    Simon, Ronald
    Gnant, Michael
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
    CastiglioneGertsch, M
    Goldhirsch, A
    Gusterson, B
    Bettelheim, R
    Reed, R
    Gusset, H
    Geiser, K
    Hurny, C
    Bernhard, J
    Hangartner, A
    Maibach, R
    Pedowski, R
    Gelber, R
    Price, K
    Peterson, H
    Zelen, M
    Isley, M
    Hinkle, R
    Kay, RG
    Holdaway, IM
    Harvey, VJ
    Jagusch, MF
    Neave, L
    Mason, BM
    Evans, B
    Benjamin, CS
    Carter, JF
    Gillman, JC
    Mack, D
    BensonCooper, D
    Monfardini, S
    Galligioni, E
    Crivellari, D
    Buonadonna, A
    Massarut, S
    Rossi, C
    Candiani, E
    Carbone, A
    Volpe, R
    Trovo, MG
    Roncadin, M
    Santini, GF
    Villalta, D
    Coran, F
    Morassut, S
    Marini, G
    Simoncini, E
    Marpicati, P
    Zaniboni, A
    Sartori, U
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1385 - 1394
  • [43] Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian Breast and Colorectal Cancer Study Group trial 6
    Schmid, M
    Jakesz, R
    Samonigg, H
    Kubista, E
    Gnant, M
    Menzel, C
    Seifert, M
    Haider, K
    Taucher, S
    Mlineritsch, B
    Steindorfer, P
    Kwasny, W
    Stierer, M
    Tausch, C
    Fridrik, M
    Wette, V
    Steger, G
    Hausmaninger, H
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 984 - 990
  • [44] Comparison of the efficacy of adjuvant letrozole and anastrozole in hormone-receptor positive postmenopausal breast cancer patients.
    Sendur, Mehmet Ali Nahit
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Reply to “ESR1 gene amplification in breast cancer: a common phenomenon?”
    Frederik Holst
    Phillip Stahl
    Olaf Hellwinkel
    Ana-Maria Dancau
    Antje Krohn
    Laura Wuth
    Christian Heupel
    Annette Lebeau
    Luigi Terracciano
    Khawla Al-Kuraya
    Fritz Jänicke
    Guido Sauter
    Ronald Simon
    Nature Genetics, 2008, 40 : 810 - 812
  • [46] ESR1 gene amplification in breast cancer:: a common phenomenon?: Reply
    Holst, Frederik
    Stahl, Phillip
    Hellwinkel, Olaf
    Dancau, Ana-Maria
    Krohn, Antje
    Wuth, Laura
    Heupel, Christian
    Lebeau, Annette
    Terracciano, Luigi
    Al-Kuraya, Khawla
    Jaenicke, Fritz
    Sauter, Guido
    Simon, Ronald
    NATURE GENETICS, 2008, 40 (07) : 810 - 812
  • [47] Pharmacogenomic prediction of breast cancer treatment outcome with adjuvant tamoxifen in postmenopausal women with estrogen receptor-positive breast cancer
    Pribylova, O.
    Petruzelka, L. B.
    Argalaczova, S.
    Konopasek, B.
    Drazdakova, J.
    Slanar, O.
    Slanar, O.
    Zima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
    Maselli, Angela
    Parlato, Stefania
    Puglisi, Rossella
    Raggi, Carla
    Spada, Massimo
    Macchia, Daniele
    Pontecorvi, Giada
    Iessi, Elisabetta
    Pagano, Maria Teresa
    Cirulli, Francesca
    Gabriele, Lucia
    Care, Alessandra
    Vici, Patrizia
    Pizzuti, Laura
    Barba, Maddalena
    Matarrese, Paola
    Pierdominici, Marina
    Ortona, Elena
    CELLS, 2019, 8 (07)
  • [49] Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patients
    Elzawahry, Heba M.
    Saber, Magdy M.
    Mokhtar, Nadia M.
    Zeeneldin, Ahmed A.
    Ismail, Yahia M.
    Alieldin, Nelly H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (04) : 181 - 191
  • [50] Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy - Results of a retrospective analysis
    Debled, Marc
    MacGrogan, Gaetan
    Brouste, Veronique
    Mathoulin-Pelissier, Simone
    Durand, Michel
    Mauriac, Louis
    CANCER, 2007, 109 (11) : 2197 - 2204
12345